Professional MBA
Biotech, Pharma & MedTech Management

Master of Business Administration

Professional MBA Biotech, Pharma & MedTech Management

A new demography and aging population, chronic diseases, increased competition, as well as budget constraints demand innovative therapies, pharmaceutical and medical products and services. It is crucial for managers in pharmaceutical and medical organizations to gain an in-depth understanding and knowledge of value creation.

The Professional MBA Biotech, Pharma & MedTech Management program builds on a solid theoretical framework complemented by case studies, excursions and discussions with peers. Graduates of the program will be part of a network of successful innovators and entrepreneurs in the field and will be prepared to take over demanding managerial positions in biopharmaceutical and medical device companies in a competitive international environment.

DOUBLE ACCREDITED: The international university course is accredited by FIBAA and ACBSP. Furthermore the Danube Business School is a member of the PRME initiative launched by the United Nations.

Target Group

Executives and entrepreneurs in biotechnology, medical technology, pharmaceutical companies as well as health care organizations

Course Options
Master of Business Administration
Admission requirements
Study or work experience according to regulations
Learning format
4 Semester, part time
possible variants
Course fee
continuously possible
German and English
Regulation (Curriculum)
Study location

The Specialisation Subjects will take place in Krems, Germany and Italy.

Danube University Krems
Dr.-Karl-Dorrek-Straße 30
3500 Krems


Information Material

Information Material


Order now
Back to top


To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems, as well Google Maps for the use of depicting maps. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies and Google Maps. More information concerning privacy policy and data protection official.